Batch Details: CP10-A1
CJC-1295 5mg + Ipamorelin 5mg is a powerful peptide pairing formulated for advanced studies into endocrine regulation and growth hormone (GH) pathways. Together, these peptides target distinct mechanisms to produce a synergistic effect on GH secretion, making them valuable tools for metabolic and regenerative research.
Peptide Components
CJC-1295 (5mg):
A synthetic analogue of growth hormone–releasing hormone (GHRH), engineered for extended half-life and stability. It stimulates the anterior pituitary to release growth hormone in a more sustained manner compared to native GHRH.
Ipamorelin (5mg):
A selective growth hormone–releasing peptide (GHRP) that mimics the action of ghrelin on the ghrelin receptor, promoting GH release without significant effects on appetite or cortisol. Known for its clean, targeted activity profile.
Research Significance
When combined, CJC-1295 and Ipamorelin work through complementary mechanisms (GHRH receptor + ghrelin receptor), which has been studied for:
Enhanced growth hormone secretion models
Metabolism and body composition research
Cellular recovery and repair studies
Investigations into anti-aging and regenerative pathways
Specifications
Form: Lyophilized peptide powder
Content: CJC-1295 5mg + Ipamorelin 5mg per vial
Storage: Store at -20°C; once reconstituted, use promptly under sterile lab conditions
